InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Coyne Terrance P., Chief Financial Officer. Insider active across 1 company, notably Royalty Pharma plc. In total, 28 filings have been logged. Split: 0 buy · 22 sells. Total volume traded: €31.1m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Coyne Terrance P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
9,230 shares@ US$58.5864Class A Ordinary SharesSEC:0001814876-26-000027:0
1,772 shares@ US$59.1415Class A Ordinary SharesSEC:0001814876-26-000027:1
11,002 shares0Class A Ordinary SharesSEC:0001814876-26-000025:0
64,399 shares@ US$53.97780.0098% mcap39.1% of flowClass A Ordinary SharesSEC:0001814876-26-000022:0
32,916 shares@ US$49.77840.0048% mcap15.3% of flowClass A Ordinary SharesSEC:0001814876-26-000018:0
1,875 shares@ US$49.77840.0003% mcap0.9% of flowClass A Ordinary SharesSEC:0001814876-26-000018:1
1,875 shares@ US$48.33180.7% of flowClass A Ordinary SharesSEC:0001814876-26-000016:0
32,916 shares@ US$48.331813.0% of flowClass A Ordinary SharesSEC:0001814876-26-000016:1
32,916 shares@ US$45.528710.9% of flowClass A Ordinary SharesSEC:0001814876-26-000014:0
22,487 shares@ US$46.67172.9% of flowClass A Ordinary SharesSEC:0001814876-26-000012:0
32,916 shares@ US$45.31654.1% of flowClass A Ordinary SharesSEC:0001814876-26-000010:0
26,626 shares0Class A Ordinary SharesSEC:0001814876-26-000008:0
102,581 shares@ US$42.083911.9% of flowClass A Ordinary SharesSEC:0001814876-26-000006:0
65,832 shares@ US$39.34847.3% of flowClass A Ordinary SharesSEC:0001814876-26-000004:0
65,832 shares@ US$38.41577.0% of flowClass A Ordinary SharesSEC:0001814876-26-000002:0
65,832 shares@ US$38.360110.6% of flowClass A Ordinary SharesSEC:0001814876-25-000011:0
65,832 shares@ US$39.86612.4% of flowClass A Ordinary SharesSEC:0001814876-25-000009:0
55,146 shares@ US$38.666311.6% of flowClass A Ordinary SharesSEC:0001814876-25-000007:0
65,844 shares@ US$39.304115.8% of flowClass A Ordinary SharesSEC:0001814876-25-000005:0
6,168 shares0Class A Ordinary SharesSEC:0001814876-25-000003:0
3,696 shares0Class A Ordinary SharesSEC:0001802768-25-000104:0
48,646 shares0Class A Ordinary SharesSEC:0001802768-25-000033:0
37,500 shares@ US$30.718313.7% of flowClass A Ordinary SharesSEC:0001209191-23-045463:0
37,500 shares@ US$31.073513.7% of flowClass A Ordinary SharesSEC:0001209191-23-042297:0
24,500 shares@ US$43.469913.9% of flowClass A Ordinary SharesSEC:0001209191-22-056420:0
25 of 28 declarations
About Coyne Terrance P.
Coyne Terrance P. is Executive Vice President and Chief Financial Officer at Royalty Pharma plc, listed on XNAS. Across 25 filings, the 25 sampled filings from 2021-05-11 to 2026-05-28 are sales, for a total of EUR 30541316, with top filings of EUR 3643296.425396086 on 2026-02-04, EUR 2987165.777662685 on 2026-05-28, and EUR 2262178.35182684 on 2025-12-03.
